Minirin (Desmopressin Acetate)

Desmopressin, the active ingredient in Minirin, is a synthetic vasopressin analog presented as a injectable solution for intramuscular, intravenous, subcutaneous use. It treats central diabetes insipidus, nocturnal enuresis, and is used as adjunct therapy in hemophilia A. GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway to manage disorders of water balance and bleeding. - Central diabetes insipidus: reduces excessive urine output by increasing renal water reabsorption. - Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine. - Hemophilia A (adjunct therapy): enhances clot stability by raising plasma factor VIII levels.

Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache - Nausea - Mild hyponatraemia - Nasal congestion

Serious or Rare Side Effects: - Severe hyponatraemia with seizures or coma - Allergic reactions, including anaphylaxis

Use of Minirin requires careful clinical monitoring. - Renal function: adjust use in severe renal impairment. - Electrolyte monitoring: check serum sodium regularly. - Fluid restriction: limit excessive water intake to avoid hyponatraemia. - Cardiovascular disease: use cautiously in patients with heart failure. - Pregnancy: safety not established; avoid unless clearly needed. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Desmopressin can interact with several drug classes.

Major Interactions (Avoid): - Concomitant antidiuretic agents (e.g., carbamazepine): may cause severe hyponatraemia. - NSAIDs: can potentiate antidiuretic effect and increase water retention.

Moderate Interactions (Monitor Closely): - Diuretics, especially thiazides: may alter fluid and electrolyte balance. - Anticoagulants: desmopressin can increase bleeding time; monitor coagulation parameters. - Opioids: may enhance hypotensive effects.